242 related articles for article (PubMed ID: 32556496)
1. Current trends in cancer immunotherapy: a literature-mining analysis.
Pouliliou S; Nikolaidis C; Drosatos G
Cancer Immunol Immunother; 2020 Dec; 69(12):2425-2439. PubMed ID: 32556496
[TBL] [Abstract][Full Text] [Related]
2. Global research trends on immunotherapy in cancer: A bibliometric analysis.
Yao Z; Lin Z; Wu W
Hum Vaccin Immunother; 2023 Aug; 19(2):2219191. PubMed ID: 37314453
[TBL] [Abstract][Full Text] [Related]
3. Identifying research themes and trends in the top 20 cancer journals through textual analysis.
Zengul AG; Zengul FD; Ozaydin B; Oner N; Fiveash JB
J Cancer Policy; 2021 Dec; 30():100313. PubMed ID: 35559806
[TBL] [Abstract][Full Text] [Related]
4. Large-scale database mining reveals hidden trends and future directions for cancer immunotherapy.
Kather JN; Berghoff AS; Ferber D; Suarez-Carmona M; Reyes-Aldasoro CC; Valous NA; Rojas-Moraleda R; Jäger D; Halama N
Oncoimmunology; 2018; 7(7):e1444412. PubMed ID: 29900054
[TBL] [Abstract][Full Text] [Related]
5. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
[No Abstract] [Full Text] [Related]
6. Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study.
Zhong W; Shen Z; Wu Y; Mao X; Kong J; Wu W
Front Immunol; 2022; 13():1014981. PubMed ID: 36389756
[TBL] [Abstract][Full Text] [Related]
7. Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis.
Liu Y; Li S; Chen L; Lin L; Xu C; Qiu H; Li X; Cao H; Liu K
Front Immunol; 2024; 15():1341596. PubMed ID: 38380323
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
9. Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy.
Pan C; Liu H; Robins E; Song W; Liu D; Li Z; Zheng L
J Hematol Oncol; 2020 Apr; 13(1):29. PubMed ID: 32245497
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.
Kumar AR; Devan AR; Nair B; Vinod BS; Nath LR
Mol Biol Rep; 2021 Dec; 48(12):8075-8095. PubMed ID: 34671902
[TBL] [Abstract][Full Text] [Related]
11. Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences.
Chung CK; Da Silva CG; Kralisch D; Chan A; Ossendorp F; Cruz LJ
J Control Release; 2018 Sep; 285():56-66. PubMed ID: 30008371
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapies for pediatric cancer: current landscape and future perspectives.
Hutzen B; Paudel SN; Naeimi Kararoudi M; Cassady KA; Lee DA; Cripe TP
Cancer Metastasis Rev; 2019 Dec; 38(4):573-594. PubMed ID: 31828566
[TBL] [Abstract][Full Text] [Related]
13. Pediatric literature trends: high-level analysis using text-mining.
Levy-Mendelovich S; Barbash Y; Budnik I; Levy-Erez D; Somech R; Soffer S; Furth S; Klang E
Pediatr Res; 2021 Jul; 90(1):212-215. PubMed ID: 33731817
[TBL] [Abstract][Full Text] [Related]
14. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.
Osipov A; Murphy A; Zheng L
Adv Cancer Res; 2019; 143():63-144. PubMed ID: 31202363
[TBL] [Abstract][Full Text] [Related]
15. Global research trends on B7-H3 for cancer immunotherapy: A bibliometric analysis (2012-2022).
Huang X; Guo J; Wang S; Lin Z; Zhao S; Li W; Wang Y; Zhu C; Lv J; Qiu W
Hum Vaccin Immunother; 2023 Aug; 19(2):2246498. PubMed ID: 37635349
[TBL] [Abstract][Full Text] [Related]
16. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
17. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
18. Advances in immunotherapy for cervical cancer.
Wendel Naumann R; Leath CA
Curr Opin Oncol; 2020 Sep; 32(5):481-487. PubMed ID: 32740092
[TBL] [Abstract][Full Text] [Related]
19. Clinical development of immunotherapy for prostate cancer.
Noguchi M; Koga N; Igawa T; Itoh K
Int J Urol; 2017 Sep; 24(9):675-680. PubMed ID: 28636142
[TBL] [Abstract][Full Text] [Related]
20. Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sun C; Xu S
Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
